000 01446 a2200445 4500
005 20250514012404.0
264 0 _c20011220
008 200112s 0 0 eng d
022 _a0033-3158
024 7 _a10.1007/s002130100813
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBarnas, C
245 0 0 _aIn vivo (123)I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients.
_h[electronic resource]
260 _bPsychopharmacology
_cSep 2001
300 _a236-42 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aDibenzothiepins
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIodobenzenes
650 0 4 _aMale
650 0 4 _aNeostriatum
_xdiagnostic imaging
650 0 4 _aRadiopharmaceuticals
650 0 4 _aReceptors, Dopamine D2
_xdrug effects
650 0 4 _aSchizophrenia
_xdiagnostic imaging
650 0 4 _aTomography, Emission-Computed, Single-Photon
700 1 _aQuiner, S
700 1 _aTauscher, J
700 1 _aHilger, E
700 1 _aWilleit, M
700 1 _aKüfferle, B
700 1 _aAsenbaum, S
700 1 _aBrücke, T
700 1 _aRao, M L
700 1 _aKasper, S
773 0 _tPsychopharmacology
_gvol. 157
_gno. 3
_gp. 236-42
856 4 0 _uhttps://doi.org/10.1007/s002130100813
_zAvailable from publisher's website
999 _c11524635
_d11524635